A lab-designed protein mimicking both insulin and glucagon has shown promising results for controlling blood sugar in Type 1 diabetes The formulation may not require ...
Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is ...
Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue ...
CHICAGO & DUBLIN--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...
A revolutionary new study using only materials derived from humans has revealed that insulin-producing beta cells can change their function in diabetes -- and that this change may be reversible. A ...
Machinery inside cells can add sugar molecules to proteins and peptides to change their function and properties. So far, researchers have found sites of O-glycosylation—in which a sugar gets attached ...
CHICAGO & DUBLIN--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback